The Icos Alumni: Where Are They Now?

Leslie Milligan, senior clinical data manager, i3StatProbe

Rosemary Monaghan, biotechnology professional

Susan Moon, freelance medical writer

Robin Moore, vice president of worldwide procurement, Getty Images [Added 12/30/09]

Amy Moro, quality assurance analyst, Quidel

Michael Moro, senior project manager of clinical supplies, Bilcare GCS

Steve Murdock, partner, life sciences practice leader, Allen Austin Executive Search

Aileen Murphy, director of biometrics, Seattle Genetics [Added 12/30/09]

Colleen Murphy, lab supply coordinator, MDRNA

Sean O’Dea, vice president of intellectual property, 3-V Biosciences

Joshua Odingo, director of chemistry, Infectious Disease Research Institute

Amy Oliver, chemicals professional

Harch Ooi, senior scientist, process chemistry, Seattle Genetics

Mark Orme, group leader of chemistry, Acucela

Karen Osofsky Michelson, senior manager of talent acquisition, Amazon.com

Karen Parker, clinical trial manager, Genentech

Leland Paul, vice president of process development, CMC Icos

Noah Pefaur, staff scientist, Novo Nordisk

Sissy Peterman, clinical research manager, Calistoga Pharmaceuticals

Scott Peterson, vice president of research and development, Oncothyreon

Tony Phan, manufacturing manager, Infectious Disease Research Institute

Louise Pobanz, finance director, CMC Icos

Tamara Potter, clinical research associate, Medicis Technologies

John Pribble, vice president of medical affairs, ZymoGenetics

Jeffrey Price, engineering technician, CMC Icos

Mark Prudhon, clinical supply manager, Seattle Genetics

Kamal Puri, principal scientist, head of biology, Calistoga Pharmaceuticals

Carol Raport, senior scientist, VLST

George Rathmann, retired

Padma Ravikumar, senior research associate, Trubion Pharmaceuticals

Mark Reed, director of medicinal chemistry, Treventis

Rob Rees, senior systems engineer, CMC Icos

Mark Rice, staff scientist, CMC Icos

Maha Rizk, scientist

Kathy Rogers, associate director, statistical programming, ZymoGenetics

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.